Advisor Group Holdings »

Celldex Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 760 41.97
2023-12-31 $22k 547 39.66
2023-09-30 $19k 693 27.52
2023-06-30 $28k 810 33.93
2023-03-31 $33k 908 35.98
2022-12-31 $39k 965 40.00
2022-09-30 $31k 1.0k 30.00
2022-06-30 $31k 1.0k 30.00
2022-03-31 $29k 978 30.00
2021-12-31 $38k 939 40.00
2021-09-30 $46k 912 50.00
2021-06-30 $32k 922 35.00
2021-03-31 $18k 922 20.00
2020-12-31 $19k 935 20.00
2020-09-30 $20k 1.3k 15.00
2020-06-30 $17k 1.3k 12.50
2020-03-31 $0 954 0.00